# AstraZeneca (Brazil)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/astrazeneca-brazil/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 61.6 |
| Citations | 1,020,034 |
| City | São Paulo |
| Country | BR |
| Description | AstraZeneca (Brazil) is a research organisation in São Paulo, BR. OpenAlex records 3,744 works and 1,020,034 citations for it. 1,828 researchers list it as their most recent affiliation. |
| Homepage | https://www.astrazeneca.com/ |
| OpenAlex ID | https://openalex.org/I4210116875 |
| Researchers | 1,828 |
| ROR ID | https://ror.org/026m9xy48 |
| Type | company |
| Works | 3,744 |

## University papers

Showing 12 of 80.

- [Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer](https://scholariq.org/papers/durvalumab-after-chemoradiotherapy-in-stage-iii-non-small-cell-lung-cancer/)
- [Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC](https://scholariq.org/papers/overall-survival-with-durvalumab-after-chemoradiotherapy-in-stage-iii-nsclc/)
- [Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection/)
- [Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association](https://scholariq.org/papers/cardiovascular-kidney-metabolic-health-a-presidential-advisory-from-the-american/)
- [Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/albiglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-and/)
- [Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and/)
- [A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association](https://scholariq.org/papers/a-synopsis-of-the-evidence-for-the-science-and-clinical-management-of/)
- [Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/sotagliflozin-in-patients-with-diabetes-and-chronic-kidney-disease/)
- [Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline](https://scholariq.org/papers/management-of-hyperglycemia-in-hospitalized-patients-in-non-critical-care/)
- [Excess Mortality among Persons with Type 2 Diabetes](https://scholariq.org/papers/excess-mortality-among-persons-with-type-2-diabetes/)
- [SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials](https://scholariq.org/papers/sglt2-inhibitors-in-patients-with-heart-failure-a-comprehensive-meta-analysis-of/)

## University researchers

- [Mikhail Kosiborod](https://scholariq.org/researchers/mikhail-kosiborod/)
- [Lars‐Gunnar Gunnarsson](https://scholariq.org/researchers/lars-gunnar-gunnarsson/)
- [Emmette R. Hutchison](https://scholariq.org/researchers/emmette-r-hutchison/)
- [Adrian Kielhorn](https://scholariq.org/researchers/adrian-kielhorn/)

## University top topics

Showing 8 of 25.

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Chemical Synthesis and Analysis](https://scholariq.org/topics/chemical-synthesis-and-analysis/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.